Elemene Augments the Effects of Anti‐PD‐1 Immunotherapy on Hepatocellular Carcinoma by Regulating the miR‐130a‐5p/SPP/MHC‐I Axis
Advanced Science · 2026
DOI: 10.1002/advs.202511887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Menglan Wang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, School of Pharmacy, Hangzhou Normal University, Department…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs, Sesquiterpenes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Administration of Traditional Chinese Medicine & Zhejiang Province, Hangzhou Normal University Dengfeng Project - Clinical Medicine Revitalization Plan Jiande Hospital Special Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Immune checkpoint inhibitors, particularly PD‐1 inhibitors, constitute the cornerstone of first‐line treatment for hepatocellular carcinoma (HCC). However, suboptimal overall response rates persist alongside dual challenges: immune‐related toxicities and immunosuppressive tumor microenvironment. Combination therapies represent a pivotal strategy to overcome these limitations. In recent years, traditional Chinese medicine has gained significant attention. Elemene, a small‐molecule compound derived from Curcuma wenyujin , has garnered attention for its immunomodulatory potential and demonstrates clinical efficacy in combination therapies. Nevertheless, its synergistic mechanisms with immunotherapy remain incompletely characterized. This study demonstrates for the first time that elemene modulates the miR‐130a‐5p/SPP/MHC‐I axis, resulting in an enhanced diversity and abundance of antigen/MHC‐I complexes on the surface of HCC cells. This mechanism promotes the recognition and elimination of HCC cells by cytotoxic T lymphocytes, thereby augmenting the antitumor immune efficacy of PD‐1. Moreover, the functional significance of the miR‐130a‐5p/SPP/MHC‐I axis in modulating the tumor immune microenvironment is systematically validated through in vitro and in vivo HCC models, as well as in clinical patient specimens. These findings underscore the potential of combining elemene with anti‐PD‐1 therapy as a safe and effective treatment strategy for HCC, offering significant translational promise for improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, School of Pharmacy, Hangzhou Normal University, Department of Hepatology, the Affiliated Hospital of Hangzhou Normal University,…
- Faculty of Chinese Medicine and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao, 999078, China.
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, NHC Key Laboratory of Combined Multi-organ Transplantation, Key Laboratory…
- Department of Oncology and Vascular Intervention, Clinical Oncology School of Fujian Medical University, Fujan Cancer Hospital, Fuzhou, Fujian, 350001, China.
- Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan (Hangzhou) Hospital, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, 310015, China.
ORCID-Profile: Jianxiang Chen, Tian Xie
Förderung
- National Administration of Traditional Chinese Medicine & Zhejiang Province
- Hangzhou Normal University Dengfeng Project - Clinical Medicine Revitalization Plan Jiande Hospital Special Project
- National Natural Science Foundation of China
- Traditional Chinese Medicine Science and Technology Project of Zhejiang Province
- Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
- Start-up Grant of Hangzhou Normal University
- Postgraduate research innovation project of Hangzhou Normal University
Zitieren
APA
Wang, M., Sun, M., Dong, H., Zhang, X., Zhang, J., Zhang, Z., Ni, M., Li, L., Pei, Y., Chen, X., Li, Q., Bu, F., Huang, J., Jiang, L., Fang, Z., Chen, X., Chen, J., Qiao, Y., & Xie, T. (2026). Elemene Augments the Effects of Anti‐PD‐1 Immunotherapy on Hepatocellular Carcinoma by Regulating the miR‐130a‐5p/SPP/MHC‐I Axis. Advanced Science. https://doi.org/10.1002/advs.202511887
Vancouver
Wang M, Sun M, Dong H, Zhang X, Zhang J, Zhang Z, et al. Elemene Augments the Effects of Anti‐PD‐1 Immunotherapy on Hepatocellular Carcinoma by Regulating the miR‐130a‐5p/SPP/MHC‐I Axis. Advanced Science. 2026. doi:10.1002/advs.202511887
BibTeX
@article{Wang2026,
author = {Wang, Menglan and Sun, Mengqing and Dong, Heng and Zhang, Xiaoting and Zhang, Jingbo and Zhang, Zhengguo and Ni, Mengjie and Li, Lina and Pei, Yunxin and Chen, Xiaoyu and Li, Qian and Bu, Fangtian and Huang, Jiacheng and Jiang, Liangyu and Fang, Zhuting and Chen, Xuliang and Chen, Jianxiang and Qiao, Yiting and Xie, Tian},
title = {Elemene Augments the Effects of Anti‐PD‐1 Immunotherapy on Hepatocellular Carcinoma by Regulating the miR‐130a‐5p/SPP/MHC‐I Axis},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202511887}
}
EUVIMED